Jonathan Mansbach

Publications

1. Nirsevimab decreased the subsequent risk of respiratory syncytial virus infection and wheezing in the 2023-2024 RSV season. Pediatr Res. 2025 Jan 09. View Abstract
2. Increasing Incidence of Serious Head and Neck Infections among Children in the United States, 2018-2023. J Pediatr. 2024 Dec 28; 279:114458. View Abstract
3. Integrated nasopharyngeal airway metagenome and asthma genetic risk endotyping of severe bronchiolitis in infancy and risk of childhood asthma. Eur Respir J. 2024 Dec; 64(6). View Abstract
4. Integrated-omics analysis with explainable deep networks on pathobiology of infant bronchiolitis. NPJ Syst Biol Appl. 2024 Aug 22; 10(1):93. View Abstract
5. Influenza and COVID-19 Vaccination Rates Among Children Receiving Long-Term Ventilation. JAMA Netw Open. 2024 Aug 01; 7(8):e2430989. View Abstract
6. Nasal microRNA signatures for disease severity in infants with respiratory syncytial virus bronchiolitis: a multicentre prospective study. BMJ Open Respir Res. 2024 Jul 31; 11(1). View Abstract
7. Race-Neutral Equations and Pulmonary Function Test Interpretation in Two Pediatric Cohorts. J Pediatr. 2024 Oct; 273:114124. View Abstract
8. Misclassification of Both Influenza Infection and Oseltamivir Exposure Status in Administrative Data. JAMA Pediatr. 2024 Feb 01; 178(2):201-203. View Abstract
9. Trends in emergency department visits for bronchiolitis, 1993-2019. Pediatr Pulmonol. 2024 Apr; 59(4):930-937. View Abstract
10. Respiratory Virus-Specific Nasopharyngeal Lipidome Signatures and Severity in Infants With Bronchiolitis: A Prospective Multicenter Study. J Infect Dis. 2023 11 11; 228(10):1410-1420. View Abstract
11. Questionable Safety of Proton Pump Inhibitor Use in Children. JAMA Pediatr. 2023 Oct 01; 177(10):1010-1012. View Abstract
12. Association between severe bronchiolitis in infancy and age 6-year lung function. Respir Med. 2023 11; 218:107401. View Abstract
13. Nasopharyngeal fungal subtypes of infant bronchiolitis and disease severity risk. EBioMedicine. 2023 Sep; 95:104742. View Abstract
14. Association between Early Childhood Vitamin D Status and Age 6-Year Lung Function among Children with a History of Severe Bronchiolitis in Infancy. Nutrients. 2023 May 19; 15(10). View Abstract
15. Factors associated with mild bronchiolitis in young infants. J Am Coll Emerg Physicians Open. 2023 Jun; 4(3):e12966. View Abstract
16. Immunoglobulin E-virus phenotypes of infant bronchiolitis and risk of childhood asthma. Front Immunol. 2023; 14:1187065. View Abstract
17. Recurrent wheezing phenotypes after severe bronchiolitis and progression to asthma. J Allergy Clin Immunol Glob. 2023 Feb; 2(1):84-87. View Abstract
18. Integrated relationship of nasopharyngeal airway host response and microbiome associates with bronchiolitis severity. Nat Commun. 2022 08 30; 13(1):4970. View Abstract
19. Association of Nasopharyngeal and Serum Glutathione Metabolism with Bronchiolitis Severity and Asthma Risk: A Prospective Multicenter Cohort Study. Metabolites. 2022 Jul 22; 12(8). View Abstract
20. Nasopharyngeal metatranscriptome profiles of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study. Eur Respir J. 2022 07; 60(1). View Abstract
21. Total immunoglobulin E in infant bronchiolitis and risk of developing asthma. J Allergy Clin Immunol Pract. 2022 10; 10(10):2761-2763.e2. View Abstract
22. Airway Bacterial Colonization, Biofilms and Blooms, and Acute Respiratory Infection. Pediatr Crit Care Med. 2022 10 01; 23(10):e476-e482. View Abstract
23. Proteomics endotyping of infants with severe bronchiolitis and risk of childhood asthma. Allergy. 2022 11; 77(11):3350-3361. View Abstract
24. COVID-19-Associated Croup in Children. Pediatrics. 2022 06 01; 149(6). View Abstract
25. Nasopharyngeal airway dual-transcriptome of infants with severe bronchiolitis and risk of childhood asthma: A multicenter prospective study. J Allergy Clin Immunol. 2022 10; 150(4):806-816. View Abstract
26. Confirming racial/ethnic disparities in the management of severe bronchiolitis. Am J Emerg Med. 2022 08; 58:333-335. View Abstract
27. Bacterial Signatures of Paediatric Respiratory Disease: An Individual Participant Data Meta-Analysis. Front Microbiol. 2021; 12:711134. View Abstract
28. Role of nasal microbiota and host response in infants with respiratory syncytial virus infection: Causal questions about respiratory outcomes. J Allergy Clin Immunol. 2022 03; 149(3):898-900. View Abstract
29. Serum Soluble Receptor for Advanced Glycation End Products in Infants With Bronchiolitis: Associations With Acute Severity and Recurrent Wheeze. Clin Infect Dis. 2021 11 02; 73(9):e2665-e2672. View Abstract
30. Severe bronchiolitis profiles and risk of asthma development in Finnish children. J Allergy Clin Immunol. 2022 04; 149(4):1281-1285.e1. View Abstract
31. Late Pre-term Infants with Severe Bronchiolitis and Risk of Asthma by Age 5 Years. J Pediatr. 2022 02; 241:247-250.e1. View Abstract
32. Urinary Tract Infections in Children with Vesicoureteral Reflux Are Accompanied by Alterations in Urinary Microbiota and Metabolome Profiles. Eur Urol. 2022 02; 81(2):151-154. View Abstract
33. Proteome signature difference between respiratory viruses is associated with severity of bronchiolitis. Pediatr Allergy Immunol. 2021 11; 32(8):1869-1872. View Abstract
34. Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma. Nat Commun. 2021 06 14; 12(1):3601. View Abstract
35. Utility of Inflammatory Markers in Hospitalized Children With Skin Erythema. Hosp Pediatr. 2021 06; 11(6):627-631. View Abstract
36. Integrated associations of nasopharyngeal and serum metabolome with bronchiolitis severity and asthma: A multicenter prospective cohort study. Pediatr Allergy Immunol. 2021 07; 32(5):905-916. View Abstract
37. Detection of Respiratory Syncytial Virus or Rhinovirus Weeks After Hospitalization for Bronchiolitis and the Risk of Recurrent Wheezing. J Infect Dis. 2021 02 03; 223(2):268-277. View Abstract
38. A joint modeling approach for longitudinal microbiome data improves ability to detect microbiome associations with disease. PLoS Comput Biol. 2020 12; 16(12):e1008473. View Abstract
39. Integrated-omics endotyping of infants with rhinovirus bronchiolitis and risk of childhood asthma. J Allergy Clin Immunol. 2021 06; 147(6):2108-2117. View Abstract
40. Pediatric Hospitalizations During the COVID-19 Pandemic. Pediatrics. 2020 12; 146(6). View Abstract
41. A comparison of childhood asthma case definitions based on parent-reported data. Ann Epidemiol. 2021 03; 55:64-68.e4. View Abstract
42. Association of endemic coronaviruses with nasopharyngeal metabolome and microbiota among infants with severe bronchiolitis: a prospective multicenter study. Pediatr Res. 2021 05; 89(7):1594-1597. View Abstract
43. Being Mindful About Follow-up Care After Pediatric Hospitalization for Bronchiolitis. JAMA Pediatr. 2020 09 01; 174(9):e201945. View Abstract
44. Machine learning-based prediction of acute severity in infants hospitalized for bronchiolitis: a multicenter prospective study. Sci Rep. 2020 07 03; 10(1):10979. View Abstract
45. Respiratory viruses are associated with serum metabolome among infants hospitalized for bronchiolitis: A multicenter study. Pediatr Allergy Immunol. 2020 10; 31(7):755-766. View Abstract
46. Severe Coronavirus Bronchiolitis in the Pre-COVID-19 Era. Pediatrics. 2020 09; 146(3). View Abstract
47. Association of rhinovirus species with nasopharyngeal metabolome in bronchiolitis infants: A multicenter study. Allergy. 2020 09; 75(9):2379-2383. View Abstract
48. In infants with severe bronchiolitis: dual-transcriptomic profiling of nasopharyngeal microbiome and host response. Pediatr Res. 2020 08; 88(2):144-146. View Abstract
49. Increased Moraxella and Streptococcus species abundance after severe bronchiolitis is associated with recurrent wheezing. J Allergy Clin Immunol. 2020 02; 145(2):518-527.e8. View Abstract
50. Trends in Bronchiolitis Hospitalizations in the United States: 2000-2016. Pediatrics. 2019 12; 144(6). View Abstract
51. Bronchiolitis severity is related to recurrent wheezing by age 3 years in a prospective, multicenter cohort. Pediatr Res. 2020 02; 87(3):428-430. View Abstract
52. Respiratory Virus Epidemiology Among US Infants With Severe Bronchiolitis: Analysis of 2 Multicenter, Multiyear Cohort Studies. Pediatr Infect Dis J. 2019 08; 38(8):e180-e183. View Abstract
53. Association of respiratory viruses with serum metabolome in infants with severe bronchiolitis. Pediatr Allergy Immunol. 2019 12; 30(8):848-851. View Abstract
54. Association of Serum Albumin With Apnea in Infants With Bronchiolitis: A Secondary Analysis of Data From the MARC-35 Study. JAMA Netw Open. 2019 07 03; 2(7):e197100. View Abstract
55. Association of Rhinovirus C Bronchiolitis and Immunoglobulin E Sensitization During Infancy With Development of Recurrent Wheeze. JAMA Pediatr. 2019 06 01; 173(6):544-552. View Abstract
56. Serum Metabolome Is Associated With the Nasopharyngeal Microbiota and Disease Severity Among Infants With Bronchiolitis. J Infect Dis. 2019 05 24; 219(12):2005-2014. View Abstract
57. Haemophilus-Dominant Nasopharyngeal Microbiota Is Associated With Delayed Clearance of Respiratory Syncytial Virus in Infants Hospitalized for Bronchiolitis. J Infect Dis. 2019 05 05; 219(11):1804-1808. View Abstract
58. Rhinovirus Species in Children With Severe Bronchiolitis: Multicenter Cohort Studies in the United States and Finland. Pediatr Infect Dis J. 2019 03; 38(3):e59-e62. View Abstract
59. Association of type 2 cytokines in severe rhinovirus bronchiolitis during infancy with risk of developing asthma: A multicenter prospective study. Allergy. 2019 07; 74(7):1374-1377. View Abstract
60. Association between rhinovirus species and nasopharyngeal microbiota in infants with severe bronchiolitis. J Allergy Clin Immunol. 2019 05; 143(5):1925-1928.e7. View Abstract
61. Circulating 25-hydroxyvitamin D, nasopharyngeal microbiota, and bronchiolitis severity. Pediatr Allergy Immunol. 2018 12; 29(8):877-880. View Abstract
62. Tracheal Microbiota in Patients With a Tracheostomy Before, During and After an Acute Respiratory Infection. Pediatr Infect Dis J. 2018 11; 37(11):e269-e271. View Abstract
63. Vitamin D Status at the Time of Hospitalization for Bronchiolitis and Its Association with Disease Severity. J Pediatr. 2018 12; 203:416-422.e1. View Abstract
64. Severe bronchiolitis profiles and risk of recurrent wheeze by age 3 years. J Allergy Clin Immunol. 2019 04; 143(4):1371-1379.e7. View Abstract
65. Overcoming the Bronchiolitis Blues: Embracing Global Collaboration and Disease Heterogeneity. Pediatrics. 2018 09; 142(3). View Abstract
66. Nasopharyngeal CCL5 in infants with severe bronchiolitis and risk of recurrent wheezing: A multi-center prospective cohort study. Clin Exp Allergy. 2018 08; 48(8):1063-1067. View Abstract
67. Serum 25-hydroxyvitamin D, metabolome, and bronchiolitis severity among infants-A multicenter cohort study. Pediatr Allergy Immunol. 2018 06; 29(4):441-445. View Abstract
68. Multicenter Study of Albuterol Use Among Infants Hospitalized with Bronchiolitis. West J Emerg Med. 2018 May; 19(3):475-483. View Abstract
69. Respiratory Syncytial Virus and Rhinovirus Bronchiolitis Are Associated With Distinct Metabolic Pathways. J Infect Dis. 2018 03 13; 217(7):1160-1169. View Abstract
70. Circulating 25-hydroxyvitamin D, nasopharyngeal airway metabolome, and bronchiolitis severity. Allergy. 2018 05; 73(5):1135-1140. View Abstract
71. RSV vs. rhinovirus bronchiolitis: difference in nasal airway microRNA profiles and NF?B signaling. Pediatr Res. 2018 03; 83(3):606-614. View Abstract
72. The association between anterior nares and nasopharyngeal microbiota in infants hospitalized for bronchiolitis. Microbiome. 2018 01 03; 6(1):2. View Abstract
73. Nasal Airway Microbiota Profile and Severe Bronchiolitis in Infants: A Case-control Study. Pediatr Infect Dis J. 2017 Nov; 36(11):1044-1051. View Abstract
74. Associations of Nasopharyngeal Metabolome and Microbiome with Severity among Infants with Bronchiolitis. A Multiomic Analysis. Am J Respir Crit Care Med. 2017 10 01; 196(7):882-891. View Abstract
75. Serum LL-37 Levels Associated With Severity of Bronchiolitis and Viral Etiology. Clin Infect Dis. 2017 Sep 15; 65(6):967-975. View Abstract
76. The temporal dynamics of the tracheal microbiome in tracheostomised patients with and without lower respiratory infections. PLoS One. 2017; 12(8):e0182520. View Abstract
77. Clinical Profiles of Respiratory Syncytial Virus Subtypes A AND B Among Children Hospitalized with Bronchiolitis. Pediatr Infect Dis J. 2017 08; 36(8):808-810. View Abstract
78. Multicenter Observational Study of the Use of Nebulized Hypertonic Saline to Treat Children Hospitalized for Bronchiolitis From 2008 to 2014. Hosp Pediatr. 2017 Jul 31. View Abstract
79. Sphingolipid metabolism potential in fecal microbiome and bronchiolitis in infants: a case-control study. BMC Res Notes. 2017 Jul 26; 10(1):325. View Abstract
80. The relationship between nasopharyngeal CCL5 and microbiota on disease severity among infants with bronchiolitis. Allergy. 2017 Nov; 72(11):1796-1800. View Abstract
81. Household siblings and nasal and fecal microbiota in infants. Pediatr Int. 2017 Apr; 59(4):473-481. View Abstract
82. Serum cathelicidin, nasopharyngeal microbiota, and disease severity among infants hospitalized with bronchiolitis. J Allergy Clin Immunol. 2017 04; 139(4):1383-1386.e6. View Abstract
83. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis. Eur Respir J. 2016 11; 48(5):1329-1339. View Abstract
84. The Fecal Microbiota Profile and Bronchiolitis in Infants. Pediatrics. 2016 07; 138(1). View Abstract
85. A clustering approach to identify severe bronchiolitis profiles in children. Thorax. 2016 08; 71(8):712-8. View Abstract
86. Trends in Infectious Disease Hospitalizations in US Children, 2000 to 2012. Pediatr Infect Dis J. 2016 06; 35(6):e158-63. View Abstract
87. Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota. J Allergy Clin Immunol. 2016 06; 137(6):1909-1913.e4. View Abstract
88. Children Hospitalized with Rhinovirus Bronchiolitis Have Asthma-Like Characteristics. J Pediatr. 2016 05; 172:202-204.e1. View Abstract
89. Detection of respiratory syncytial virus and rhinovirus in healthy infants. BMC Res Notes. 2015 Nov 25; 8:718. View Abstract
90. Prenatal Versus Postnatal Tobacco Smoke Exposure and Intensive Care Use in Children Hospitalized With Bronchiolitis. Acad Pediatr. 2016 07; 16(5):446-452. View Abstract
91. Clinical Endpoints for Respiratory Syncytial Virus Prophylaxis Trials in Infants and Children in High-income and Middle-income Countries. Pediatr Infect Dis J. 2015 Oct; 34(10):1086-92. View Abstract
92. Eligibility for palivizumab prophylaxis in a cohort of children with severe bronchiolitis. Pediatr Int. 2015 Oct; 57(5):1031-4. View Abstract
93. Association Between Hyponatremia and Higher Bronchiolitis Severity Among Children in the ICU With Bronchiolitis. Hosp Pediatr. 2015 Jul; 5(7):385-9. View Abstract
94. Bordetella pertussis is an uncommon pathogen in children hospitalized with bronchiolitis during the winter season. Pediatr Infect Dis J. 2015 Jun; 34(6):566-70. View Abstract
95. Use of Cough and Cold Medications in Severe Bronchiolitis before and after a Health Advisory Warning against Their Use. J Pediatr. 2015 Jul; 167(1):196-8.e1-2. View Abstract
96. Variability of intensive care management for children with bronchiolitis. Hosp Pediatr. 2015 Apr; 5(4):175-84. View Abstract
97. Rhinovirus-induced bronchiolitis: Lack of association between virus genomic load and short-term outcomes. J Allergy Clin Immunol. 2015 Aug; 136(2):509-12.e11. View Abstract
98. Hospital course and discharge criteria for children hospitalized with bronchiolitis. J Hosp Med. 2015 Apr; 10(4):205-11. View Abstract
99. Risk factors for requiring intensive care among children admitted to ward with bronchiolitis. Acad Pediatr. 2015 Jan-Feb; 15(1):77-81. View Abstract
100. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. J Infect Dis. 2015 May 15; 211(10):1550-9. View Abstract
101. Variability in inpatient management of children hospitalized with bronchiolitis. Acad Pediatr. 2015 Jan-Feb; 15(1):69-76. View Abstract
102. Hospital length-of-stay is associated with rhinovirus etiology of bronchiolitis. Pediatr Infect Dis J. 2014 Aug; 33(8):829-34. View Abstract
103. Multicenter study of viral etiology and relapse in hospitalized children with bronchiolitis. Pediatr Infect Dis J. 2014 Aug; 33(8):809-13. View Abstract
104. Racial/ethnic differences in the presentation and management of severe bronchiolitis. J Hosp Med. 2014 Sep; 9(9):565-72. View Abstract
105. Recent evidence on the management of bronchiolitis. Curr Opin Pediatr. 2014 Jun; 26(3):328-33. View Abstract
106. Infectious pathogens and bronchiolitis outcomes. Expert Rev Anti Infect Ther. 2014 Jul; 12(7):817-28. View Abstract
107. Temporal trends in emergency department visits for bronchiolitis in the United States, 2006 to 2010. Pediatr Infect Dis J. 2014 Jan; 33(1):11-8. View Abstract
108. Nasopharyngeal Proteobacteria are associated with viral etiology and acute wheezing in children with severe bronchiolitis. J Allergy Clin Immunol. 2014 Apr; 133(4):1220-2. View Abstract
109. Apnea in children hospitalized with bronchiolitis. Pediatrics. 2013 Nov; 132(5):e1194-201. View Abstract
110. Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics. 2013 Jul; 132(1):28-36. View Abstract
111. Altitude and environmental climate effects on bronchiolitis severity among children presenting to the emergency department. J Environ Health. 2012 Oct; 75(3):8-15; quiz 54. View Abstract
112. Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis. J Allergy Clin Immunol. 2012 Oct; 130(4):1007-8.e1. View Abstract
113. Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation. Pediatrics. 2012 Sep; 130(3):e492-500. View Abstract
114. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med. 2012 Aug; 166(8):700-6. View Abstract
115. Nasopharyngeal lactate dehydrogenase concentrations predict bronchiolitis severity in a prospective multicenter emergency department study. Pediatr Infect Dis J. 2012 Jul; 31(7):767-9. View Abstract
116. National study of antibiotic use in emergency department visits for pneumonia, 1993 through 2008. Acad Emerg Med. 2012 May; 19(5):562-8. View Abstract
117. Serum 25-hydroxyvitamin D levels among Boston trainee doctors in winter. Nutrients. 2012 03; 4(3):197-207. View Abstract
118. Clinical features can help predict which infants with bronchiolitis will need hospital admission. J Pediatr. 2012 Jan; 160(1):174-5. View Abstract
119. Low serum 25-hydroxyvitamin D levels are associated with increased risk of viral coinfections in wheezing children. J Allergy Clin Immunol. 2010 Nov; 126(5):1074-6, 1076.e1-4. View Abstract
120. Insurance status and the variable management of children presenting to the emergency department with bronchiolitis. Pediatr Emerg Care. 2010 Oct; 26(10):716-21. View Abstract
121. Prospective multicenter study of bronchiolitis: predictors of an unscheduled visit after discharge from the emergency department. Acad Emerg Med. 2010 Apr; 17(4):376-82. View Abstract
122. Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States. Am J Obstet Gynecol. 2010 May; 202(5):436.e1-8. View Abstract
123. Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma. Clin Lab Med. 2009 Dec; 29(4):741-55. View Abstract
124. Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D? Pediatrics. 2009 Nov; 124(5):1404-10. View Abstract
125. Factors associated with longer emergency department length of stay for children with bronchiolitis : a prospective multicenter study. Pediatr Emerg Care. 2009 Oct; 25(10):636-41. View Abstract
126. Variability in the diagnostic labeling of nonbacterial lower respiratory tract infections: a multicenter study of children who presented to the emergency department. Pediatrics. 2009 Apr; 123(4):e573-81. View Abstract
127. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009 Feb 23; 169(4):384-90. View Abstract
128. Vitamin D, respiratory infections, and asthma. Curr Allergy Asthma Rep. 2009 Jan; 9(1):81-7. View Abstract
129. Prospective multicenter bronchiolitis study: predicting intensive care unit admissions. Acad Emerg Med. 2008 Oct; 15(10):887-94. View Abstract
130. Bronchiolitis: lingering questions about its definition and the potential role of vitamin D. Pediatrics. 2008 Jul; 122(1):177-9. View Abstract
131. Variations in admission practices for adolescents with anorexia nervosa: a North American sample. J Adolesc Health. 2008 Nov; 43(5):425-31. View Abstract
132. Prospective multicenter study of bronchiolitis: predicting safe discharges from the emergency department. Pediatrics. 2008 Apr; 121(4):680-8. View Abstract
133. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med. 2008 Feb; 15(2):111-8. View Abstract
134. US outpatient office visits for bronchiolitis, 1993-2004. Ambul Pediatr. 2007 Jul-Aug; 7(4):304-7. View Abstract
135. Evaluation of compliance with palivizumab recommendations in a multicenter study of young children presenting to the emergency department with bronchiolitis. Pediatr Emerg Care. 2007 Jun; 23(6):362-7. View Abstract
136. Variation in IRB responses to a standard, observational pediatric research protocol. Academic Emergency Medicine. 2007; 14(4):377-380. View Abstract
137. Variation in institutional review board responses to a standard, observational, pediatric research protocol. Acad Emerg Med. 2007 Apr; 14(4):377-80. View Abstract
138. Evidence Based Medicine. Comprehensive Pediatric Hospital Medicine. Zauoutis LB, Chiang VW, editors. 2007; 32-35. View Abstract
139. U.S. Outpatient office visits for bronchiolitis, 1993-2004. Ambulatory Pediatrics. 2007; 7(4):304-307. View Abstract
140. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics. 2006 Dec; 118(6):2418-23. View Abstract
141. Multicenter Study of Bronchiolitis in the Emergency Department. Oral Presentation. American Academy of Pediatrics National Convention and Exhibition. 2006. View Abstract
142. Testicular torsion and risk factors for orchiectomy. Arch Pediatr Adolesc Med. 2005 Dec; 159(12):1167-71. View Abstract
143. Bronchiolitis in US emergency departments 1992 to 2000: epidemiology and practice variation. Pediatr Emerg Care. 2005 Apr; 21(4):242-7. View Abstract
144. Variation in Admission for Adolescents with Anorexia Nervosa: A North American Sample. Poster. Society for Adolescent Medicine Annual Conference. 2005. View Abstract
145. Two children with Lyme disease presenting with persistent headache. Pediatrics. 2003; 112: e477-e479. Reprinted in Review Series Neurology. 2004; 2:10-12. View Abstract
146. Lyme disease presenting with persistent headache. Pediatrics. 2003 Dec; 112(6 Pt 1):e477-9. View Abstract
147. Which psychiatric patients board on the medical service? Pediatrics. 2003 Jun; 111(6 Pt 1):e693-8. View Abstract
148. A practical guide to prescribing oral contraceptives. Contemporary Pediatrics. 2001; 18(10):111-126. Reprinted in Contemporary OB/GYN. 2001; 46(11):87-104 and Patient Care [serial online] June. 2003. View Abstract
149. Optimizing the care of hospitalized youth. Poster. Society for Adolescent Medicine Annual Conference. 2002. View Abstract
150. Demystifying delayed puberty. Contemporary Pediatrics. 2001; 18(4): 43-60. Reprinted in Contemporary OB/GYN. 2001; 46(8):39-54. View Abstract
151. New seizures in a 6 year-old: Expanding Horizons. Contemporary Pediatrics. 1999; 16(8):25-33. View Abstract
152. Phenobarbital selectively promotes initiated cells with reduced TGF beta receptor levels. Carcinogenesis. 1996 Jan; 17(1):171-4. View Abstract
Show All Publications Show Fewer Publications